Proxy Votes Now

Home › Funds › Vanguard › Small Company Growth Portfolio

Small Company Growth Portfolio proxy voting record 2025-2026

Fund family: Vanguard · Filed by VANGUARD VARIABLE INSURANCE FUNDS (CIK 857490) · SEC series S000004394

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 4,171 with, 28 against, 2 abstentions (not counted as with management); 4 items carried no recommendation; 8 split votes are in neither count. Shareholder proposals: 8 FOR, 15 AGAINST, 1 abstained, by the filing’s own vote-source field.

Compared with Vanguard as a whole

The same two figures as Vanguard’s manager page (1,379,791 ballot items across 136 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsVanguardItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)96.8%4,07694.5%1,082,514
Backed environmental and social shareholder proposals at US companiesn/a10.9%6,718

Where this fund voted differently from most Vanguard funds

Each ballot item this fund voted is set against the votes of the other Vanguard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Vanguard funds on 22 items (0.5% of the 4,057 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Vanguard fundsMgmtResult
Lattice Semiconductor Corporation2026-05-01To approve on a non-binding, advisory basis, our Named Executive Officer's compensation.AgainstFOR — 21 of 21 Vanguard fundsAgainstApproved, 86.5% support
First American Financial Corporation2026-05-12Election of Class I director Nominees: Deborah L. WahlAgainstFOR — 18 of 18 Vanguard fundsAgainstElected, 90.8% support
Tandem Diabetes Care, Inc.2026-05-20To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changeAgainstFOR — 17 of 17 Vanguard fundsForApproved, 83.5% support
Tandem Diabetes Care, Inc.2026-05-20To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher TwomeyAgainstFOR — 17 of 17 Vanguard fundsForPassed (calculated), 87.2% support
Viper Energy, Inc.2026-05-19Election of Directors: Laurie H. ArgoAgainstFOR — 16 of 16 Vanguard fundsAgainstPassed (calculated), 97.2% support
CarGurus, Inc.2026-06-03To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2025.AgainstFOR — 25 of 26 Vanguard fundsAgainstApproved, 94.3% support
ON Semiconductor Corporation2026-05-14To elect seven directors nominated by our Board of Directors: Christine Y. YanAgainstFOR — 23 of 24 Vanguard fundsAgainstPassed (calculated), 92.3% support
AAON, Inc.2026-05-12Election of Directors for a term ending in 2029: Stephen O. LeClairAgainstFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 87.1% support
Veracyte, Inc.2026-06-10The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Robert S. EpsteinAgainstFOR — 15 of 15 Vanguard fundsAgainstElected, 93.0% support
Entegris, Inc.2026-05-06Shareholder Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders.ForAGAINST — 20 of 21 Vanguard fundsAgainstFailed (calculated), 31.3% support
Entegris, Inc.2026-05-06Election of Directors: Azita Saleki-GerhardtAgainstFOR — 20 of 21 Vanguard fundsAgainstPassed (calculated), 95.7% support
Entegris, Inc.2026-05-06To approve, on an advisory basis, providing stockholders the right to call special meetings of stockholders.AbstainFOR — 20 of 21 Vanguard fundsAgainstPassed (calculated), 83.6% support
The Timken Company2026-05-08Approval, on an advisory basis, of our named executive officer compensation.AgainstFOR — 26 of 28 Vanguard fundsAgainstApproved, 74.6% support
Praxis Precision Medicines, Inc.2026-06-10To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William YoungWithholdFOR — 13 of 14 Vanguard fundsAgainstPassed (calculated), 85.5% support
Cimpress plc2025-12-17Reappoint Scott J. Vassalluzzo to Cimpress' Board of Directors to serve for a term of three years.AgainstFOR — 13 of 14 Vanguard fundsAgainstPassed (calculated), 79.1% support
Aurora Innovation, Inc.2026-05-21Election of Directors: Gloria BoylandWithholdFOR — 14 of 16 Vanguard fundsAgainstElected, 97.3% support
The Timken Company2026-05-08Shareholder Consideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percForAGAINST — 17 of 22 Vanguard fundsAgainstNot approved, 41.4% support
Lumexa Imaging Holdings, Inc.2026-06-10To elect three Class I directors to the Board of Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Brian ReganWithholdFOR — 7 of 8 Vanguard fundsAgainst—
Lumexa Imaging Holdings, Inc.2026-06-10To elect three Class I directors to the Board of Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Caitlin ZullaWithholdFOR — 7 of 8 Vanguard fundsAgainst—
Lumexa Imaging Holdings, Inc.2026-06-10To elect three Class I directors to the Board of Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Lee CooperWithholdFOR — 7 of 8 Vanguard fundsAgainst—
Viper Energy, Inc.2026-05-19The approval of an amendment to the Company's certificate of incorporation to provide that stockholders holding at least 20% of the voting power, determined on a net long basis, continuously for at least one year, may call special meetings of stockholders, and other immaterial changes.AgainstFOR — 3 of 3 Vanguard fundsAgainstApproved, 94.6% support
Trimble Inc.2026-05-26Elect Meaghan LloydWithholdFOR — 2 of 3 Vanguard fundsAgainst—

Download all 22 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 96.8% of this fund’s 4,201 such votes could be given a sector; the other 136 (3.2%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care97540.4%
Consumer Discretionary90491.0%
Technology80930.4%
Industrials55261.1%
Finance31210.3%
Energy13900.0%
Real Estate10400.0%
Consumer Staples7833.8%
Telecommunications7011.4%
Miscellaneous4500.0%
Utilities4212.4%
Basic Materials3500.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2,8713
Say-on-Pay5112
Audit-related5060
Compensation1740
Corporate Governance10515
Capital Structure551
Shareholder Rights and Defenses226
Extraordinary Transactions180
Diversity, Equity, and Inclusion11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Axogen, Inc.June 23, 2026$42M100
Churchill Downs IncorporatedApril 21, 2026$39M50
Hinge Health, Inc.June 3, 2026$38M30
Bloom Energy CorporationMay 21, 2026$37M120
Federal Signal CorporationApril 21, 2026$35M180
Comfort Systems USA, Inc.May 18, 2026$32M120
Halozyme Therapeutics, Inc.May 5, 2026$31M40
Dynatrace, Inc.August 20, 2025$31M80

Notable votes against management

MeetingCompanyProposalFundMgmt
April 30, 2026RB Global, Inc.Approval Of A Special Resolution, Requiring The Company To Adopt A Policy And Amend Its Governing Documents Accordingly That All Shareholder Meetings Will Be Held In A Hybrid Format With Both In-Person And Virtual Access As Described In The Accompanying Proxy Statement. Shareholder proposalAgainstFor
May 20, 2026Tandem Diabetes Care, Inc.To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher TwomeyAgainstFor
May 20, 2026Tandem Diabetes Care, Inc.To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL.AgainstFor
May 15, 2026Medpace Holdings, Inc.Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposalAgainstFor
May 6, 2026Entegris, Inc.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalForAgainst
January 22, 2026Jabil Inc.Vote on a stockholder proposal requesting stockholder right to act by written consent. Shareholder proposalAgainstFor
June 9, 2026Etsy, Inc.Advisory vote on a stockholder proposal to govern by majority vote. Shareholder proposalAgainstFor
May 8, 2026The Timken CompanyConsideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percentage of shareholders, as governed by state law, the power to call a special shareholder meeting. Shareholder proposalForAgainst
August 4, 2025Eagle Materials Inc.Non-binding advisory stockholder proposal requesting the declassification of our Board of Directors. Shareholder proposalForAgainst
May 11, 2026MKS Inc.A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposalAgainstFor
May 20, 2026Lumen Technologies, Inc.Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposalAgainstFor
April 30, 2026NRG Energy, Inc.To vote on a stockholder proposal to give shareholders the ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposalForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

4,263 ballot items at 525 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Small Company Growth Portfolio voted at 525 shareholder meetings of 515 companies, on 4,263 ballot items in all. Where management made a recommendation, the fund followed it on 99.3% of the items and voted against it 28 times. Its most frequent area of disagreement was corporate governance (15 of its votes against management). It voted on 26 shareholder proposals. It voted FOR the board's own proposals more often than Vanguard's funds as a whole (96.8% against 94.5%). It voted differently from most Vanguard funds on 22 items. 2 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Vanguard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.